US Stocks and Election Year Patternsby Mark Eisenberg 01.10.2024Explore how US stocks typically perform during election years and the economic implications of potential election outcomes.
CRISPR Therapeutics Faces Challenging Timesby Mark Eisenberg 24.09.2024CRISPR shares have slid 59% over three years, reflecting deeper business challenges.
MBX Biosciences Insiders Invest $10 Million in Stockby Mark Eisenberg 18.09.2024MBX insiders show confidence with a $10M stock purchase amid market challenges, signaling potential growth.
Bank of America Stock Dips as Buffett Sells Sharesby Mark Eisenberg 12.09.2024Warren Buffett's Berkshire Hathaway reduces stake in Bank of America, impacting stock prices amidst mixed analyst outlooks.
MediWound’s Q2 2024: Strong Growth Amid Challengesby Mark Eisenberg 20.08.2024MediWound Ltd. sees robust Q2 growth with NexoBrid, prepares for global expansion, despite increased financial losses.
Robinhood Stock: Piper Sandler’s Strategic Upgradeby Mark Eisenberg 18.08.2024Piper Sandler upgrades Robinhood stock to Overweight, citing a buying opportunity amid recent price pullback.
Consider Invesco QQQ Over S&P 500 for Higher Returnsby Mark Eisenberg 17.08.2024The Invesco QQQ ETF outperforms the S&P 500, driven by tech giants and innovative industries. Learn why it's a smart ...
Nikola Reports Q2 Progress in Hydrogen Expansionby Mark Eisenberg 11.08.2024Nikola Corp sees growth in hydrogen trucks, reports losses. Aiming for 14 fuel stations in North America by end of ...
Microvast’s Q2 2024 Revenue Surges to $83.7Mby Mark Eisenberg 10.08.2024Microvast reports record Q2 2024 revenue at $83.7M, up 12%. Gross margin hits 32.5% amid EMEA sales boost, despite challenges.
Personalis Inc. Raises Full-Year Revenue Guidanceby Mark Eisenberg 08.08.2024Personalis sees 35% Q2 revenue growth, lifts full-year outlook to $79-$81M.